STRYKER CORP (SYK) FY2024 Q3 P&L / Income Statement
2024-07-01 to 2024-09-30
Revenue by Business Segment
2024-07-01 to 2024-09-30
Swipe to see the full flow
Chart details
STRYKER CORP (SYK) FY2024 Q3 P&L / Income Statement
Income statement for 2024-07-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Net sales
- 5,494,000,000 US dollars
- Cost of sales
- 1,977,000,000 US dollars
- Gross profit
- 3,517,000,000 US dollars
- Total operating expenses
- 2,432,000,000 US dollars
- Operating income
- 1,085,000,000 US dollars
- Other income (expense), net
- negative 42,000,000 US dollars
- Earnings before income taxes
- 1,043,000,000 US dollars
- Income taxes
- 209,000,000 US dollars
- Net earnings
- 834,000,000 US dollars
- MedSurg and Neurotechnology
- 3,224,000,000 US dollars
- Orthopaedics and Spine
- 2,270,000,000 US dollars
- Research, development and engineering expenses
- 377,000,000 US dollars
- Selling, general and administrative expenses
- 1,896,000,000 US dollars
- Amortization of intangible assets
- 159,000,000 US dollars
- MedSurg and Neurotechnology costs (calculated)
- 2,300,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Orthopaedics and Spine costs (calculated)
- 1,627,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Reconciling items (calculated)
- 482,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
64.0%
Gross profit / revenue
Operating margin
19.7%
Operating profit / revenue
Cash conversion
176.7%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
